SESSION

C0-CHAIRS

CONFIRMED SPEAKERS—(Tentative) TOPICS

Innovative cardiovascular biomaterials

L Bordenave, J Hubbell

1. L Bordenave—Functional cardiovascular biomaterials

2. J Hubbell—Extracellular matrices as cardiovascular biomaterials

3. RT Lee—Microenvironmental design using biomaterials

4. A Khademohosseini - Nanobiomaterials safety issues

Developmental cardiovascular biology (Collaborative with Society for Cardiovascular Pathology)

FJ Schoen, G Thiene

1. AC Gittenberger-de Groot—Cell fate in cardiac development

2. G Thiene—New developments in normal and abnormal cardiac development

3. HS Baldwin—Signaling events in heart valve development

4. K Hirschi (Tentative)—Blood vessel formation and remodeling

Cardiovascular mechano-pathophysiology and tissue remodeling

D Vorp, G Garcia-Cardena

1. G Garcia-Cardena—Molecular mechanisms of mechanotransduction in atheroprotection

2. D Vorp - Abdominal aortic aneurysms: Evolving concepts in pathobiology and therapy

3. M Moses—Tissue remodeling: Overview and prospects for non-invasive monitoring

4. M Yacoub –Mechanical assist-mediated reversible cardiac dysfunction

Engineering cell-based regeneration of cardiovascular tissues

S Hoerstrup, P Menasche

1. S Hoerstrup—Heart valve and conduit engineering: Is growth possible?

2. P Menasche—Cell-based therapy for cardiac repair

3. W Zimmerman—Engineered myocardium

4. T Okano—Cell sheet engineering approaches

Challenges in clinical translation of innovative cardiovascular biology, devices and therapies (e.g. animal models, clinical trials, regulatory issues, reimbursement, etc.)

D Williams, JJ Rosen

1. FJ Schoen—Challenges in clinical translation of cardiovascular tissue engineering approaches

2. D Williams—European regulatory approaches in tissue engineering and regenerative medicine

3. K Hellman - Regulatory concerns in tissue engineering and regenerative medicine

4. JJ Rosen—Corporate considerations in innovative cardiovascular technologies